r o l a c t i n has been thought t o p l a y a r o l e i n p r e v e n t i n g m o b i l i z a t i o n of t i s s u e w a t e r i n t h e neonate. Serum l e v e l s of p r o l a c t i n a r e low i n premature newborns and t h i s may l e a d t o dec r e a s e d i n t r a c e l l u l a r w a t e r , b r a i n shrinkage, c a p i l l a r y b l e e d i n g and subsequent IVH. The h y p o t h e s i s t h a t decreased p r o l a c t i n l e v e l s c o n t r i b u t e t o development o f IVH was s t u d i e d by our group.
Serum p r o l a c t i n l e v e l s were comparable between t h e 2 groups. Our r e s u l t s do n o t s u p p o r t t h e concept of a pathogenetic r o l e f o r p r o l a c t i n i n development o f I V H .
LOW WSE ORAL CLONIDINE: A SIMPLE AND RELIABLE GGWTH HORMONE (GH) SCREFNING TEST. Roberto Lanes,

B r l d q e t .
Recker, Pave1 F o r t and Finn L i f s h i t z . Department of P e d i a t r i c s , North Shore U n i v e r s i t y Hospital, Manhasset, NY 11030, and Departnent o f P e d i a t r i c s , C o r n e l l U n i v e r s i t y Medical College, New York, NY 10021. Clonidine h a s been s h a m to b e a n e f f e c t i v e GH re1 a s i n g a g e n t i n p r e p u b e r t a l c h i l d r e n a t a dose o f 150 micrograms/M5 body s u r f a c e area, b u t a t this dose it c a n produce s i g n i f i c a n t s i d e e f f e c t s . W e have e v a l u a t e d t h e e f f i c a c y and side e f f e c t s of low d o s e o r a l c l o n i d i n e o n GH, c o r t i s o l and blood p r e s s u r e i n 24 h e a l t h y s h o r t c h i l d r e n ; t e n r e c e i v e d 100 micrograms (Group A), and f o u r t e e n 50 micrograms (Group B) . A 100 micrograms of oral c l o n i d i n e induced h i g h e r , mre s u s t a i n e d GH l e v e l s and fewer f a i l u r e s to t e s t i n g than d i d 50 micrograms. The mean * SD GH peak a t 60 minutes in group A was 14.5 * 6.3 v s 11.6 * 6.1 nq/ml i n qroup B (NS) . F a i l u r e rate (GH 10 ng/ml) was 10% i n group A and 36% in group B. C h i l d r e n who responded t o c l o n i d i n e i n group A (GHZ10 ng/ml) had s i g n i f i c a n t l y h i g h e r GH l e v e l s than d i d group B responders ( p < 0.01). A s i m i l a r , b u t s i g n i f i c a n t d r o p in cortisol was s e e n i n b o t h groups ( f m 14.5 * 6.3 to 7.8 * 2.6 ug/dl i n group A and from 16.9 * 6.7 to 12.8 * 8.4 ug/dl i n group B). Blood p r e s s u r e d i d n o t change s i g n i f i c a n t l y w i t h either d o s e used and o n l y m i l d somnolence was noted i n b o t h groups.
A s i n g l e o r a l dose o f 100 micrograms o f c l o n i d i n e , followed by 1 blood sample 60 minut% later c a n be used t o e f f e c t i v e l y and s a f e l y s c r e e n s h o r t c h i l d r e n f o r GH d e f i c i e n c y . To determine i f plasma d e s o x y c o r t i s o l (Compound S-Cmpd S) b a s a l and ACTH-stimulated response l e v e l s allow i d e n t i f i c a t i o n of p a t i e n t s with mild 11-hydroxylasr d e f i c i e n c y , t h i s hormone has been measured i n t h e following 4 groups of s u b j e c t s : (1) females p r e s e n t i n g with premature pubarche o r h i r s u t i s m i n adolescence; (2) s u b j e c t s who a r e h e t e r o z y g o t i c c a r r i e r s o r have mild 11-hydroxylase d e f i c i e n c y based on kindred s t u d i e s ; (3) normal females, post menarchial and f o l l i c u l a r phase; (4) 10 females known t o be h e t e r o z y g o t i c c a r r i e r s of 21-hydroxylase d e f i c i e n c y . (1) had Cmpd S responses g r e a t e r than normal c o n t r o l s ( 3 ) , b u t w i t h i n t h e range of those w i t h evidence of compromised 11 OHase (2) o r 21 OHase (4) a c t i o n . Five of t h e s e seven had. b a s a l l e v e l s g r e a t e r than Group 4. These p a t i e n t s could have mild 11-hydroxylase d e f i c i e n c y .
(Supported i n p a r t by Endocrine Sciences, Tarzana, CA) race have not been exa2mined. We examined t h e hypothesis t h a t serum 1,25(OH)2D would not be affected by I) breastfeeding vs formula feeding, 2) season, and, 3) race. 143 normal infants less than 18 months of age were examined. 1,25(OH)2D was measured by Eisman's method (HPLC-cytosol binding protein, normal 17 t o 44 pg/ml). Infant values were elevated vs adults (p <.001). By analysis of variance, no significant difference was found between breast-fed (58 2 4 pglml, mean 2 SE) and bottle-fed infants (66 + 4 pg/ml). Significant seasonal and racial differences were found, with winter infants having higher 1,25(OH) D (72 + 3) than summer infants (53 + 3, P <.001), and black infants (73+!3) having higher concentrations f h a h w h i t e infants (56 + 2, p < .001). Seasonal differences remained within subgroups: in whites wnter mean was 62 vs summer 50 pg/ml; in blacks winter 81 vs summer 56 pglml. No age-specific e f f e c t s were apparent within the age range studied. Thus, serum 1,25(OH)2D concentrations in infants < 18 months of a g e a r e not affected by breast vs formula feeding, and a r e increased in winter & in blacks. We speculate that differences in 1,25(OH) D concentrations may be sensitive indicators of vitamin D status in infan?y and should be taken into consideration when studies of vitamin D and calcium metabolism a r e undertaken in infants. 
ACUTE AND CHRONIC EFFECTS OF hGH O N LIPOPROTEINS IN
448
u/kg human GH (hGH) d a i l y with l i p o p r o t e i n s (HOL-C) measured b e f o r e and a t t h e end of 4 days o f hGH. Nine p a t i e n t s received
long t e n hGH 0.1 u/kg 3 times p e r week with HDL-C measured a t 3 months, 6 months and 12 months. The diagnoses were: craniopharyngioma, 4; i d i o p a t h i c GH d e f i c i e n c y , 4 ; and s e p t o -o p t i c dysplas i a , 2. Ten p a t i e n t s completed t h e a c u t e study; 9 p a t i e n t s , ( 3 F and 6 M) completed 3 months; 7 p a t i e n t s , (2 F and 5 M) completed 6 months, and 5 m completed t h e 12 month s t u d i e s . A1 1 s u b j e c t s b u t one had a d e c r e a s e i n t h e HDL-C (mean f S.E. 50.1 f 4.0 t o 41.8 f 2.9, p (0.025 -p a i r e d t t e s t ) i n t h e a c u t e phase. In t h e chronic study no s i g n i f i c a n t change o f HDL-C was noted b e f o r e and a t 3 months 6 months o r 12 months a f t e r hGH treatment. The mechanism of t h i s a c u t e decrease i n HDL-C i s u n c l e a r but could be explained by a1 t e r e d bi 1 e a c i d metabolism, apoprotei n A-1 metabolism, e f f e c t s mediated by o t h e r hormones induced by GH, o r combination o f t h e s e . The a c u t e decrease i n HDL-C and t h e absence o f a s i g n i f i c a n t change with c h r o n i c hGH observed i n t h i s study may e x p l a i n some o f t h e c o n f l i c t s reported by o t h e r i n v e s t i g a t o r s .
EFFECT OF LOW DOSE PREMARIN AND HALOTESTIN ON LIPO-PROTEIN IN TURNER SYNDROME. Tsu-Hui L i n , Rebecca T. of Ped. and i e d . , Houston, TX. Sex hormones have been shown t o a l t e r high d e n s i t y l i p o p r o t e i n c h o l e s t e r o l l e v e l s (HDL-C). Estrogens i n c r e a s e , w h i l e androgens (A) decrease, HDL-C. Some progestogens reduce HDL-C, b u t e f f e c t s of low dose combined o r a l c o n t r a c e p t i v e s remain c o n t r o v e r s i a l . Data i s s p a r s e concerning t h e e f f e c t o f low dose A therapy. 11 p a t i e n t s with Turner syndrome ( T S ) , aged 9 t o 14 y e a r s , received P r m a r i n ( P , conjugated e s t r o g e n s ) 0.15 mg (0.16 f 0.004 m g /~~) and H a l o t e s t i n ( H , Fluoxymesterone) 1 mg (1.09f0.03 m g /~~) p.0. d a i l y with t h e exception o f one g i r l who received P,H every o t h e r day. Baseline HDL-C was measured a f t e r a t l e a s t 3 months witho u t P, H and a f t e r 6 and 12 months o f therapy. All 11 g i r l s comp l e t e d 6 months and 5 g i r l s 12 months of therapy. Mean ' S.E. l e v e l s of HDL-C f o r b a s e l i n e , 6 and 12 months were 50.7 f 1.9, 45.0f 2.8 and 45.0 f 2.8 mg/dl r e s p e c t i v e l y and i n d i c a t e d s i gn i f i c a n t decrease from b a s e l i n e t o 6 month ( p c 0.01 -paired t ) and 12 month (~~0 . 0 2 5 p a i r e d t ) of therapy. Plasma t e s t o s t e r o n e , measured i n 9 g i r l s was i n t h e prepubertal range. In 3 TS g i r l s , 15, 12, 9 y e a r s , r e c e i v i n g low dose P without H f o r more than 6 months, HDL-C l e v e l s were 59, 49 and 56. Our study suggests t h a t even low dose H therapy can reduce HOL-C, and may imply t h a t low dose combined oral c o n t r a c e p t i v e s can be a s s o c i a t e d with reduced HOL-C i n normal females. G i r l s with TS o r o t h e r d i s o r d e r s who r e c e i v e A may have decreased HDLC which has been a s s o c i a t e d a s an independent r i s k f a c t o r i n coronary h e a r t d i s e a s e .
